Resolian is a leading global Contract Research Organization (CRO) that offers specialised services in GxP and non-regulated bioanalysis, drug metabolism/pharmacokinetics (DMPK), and GMP CMC analytical and materials science. The company boasts a team of over 500 experts operating across the United States, United Kingdom, and Australia, dedicated to supporting the pharmaceutical industry in various stages of drug development and compliance.

Services include:
- Accelerated Stability Studies
- ADMET
- Analytical Services
- Animal Health
- Anti-Counterfeiting Technology
- Assay Development
- Bioanalytical Services
- Biomarker Research
- Biosimilars
- Chemical Analysis
- Raw Materials
- Chemistry (CMC)
- Combinatorial
- Medicinal
- Chiral Separations
- R&D
- Chromatography
- Clinical Trials
- Manufacturing
- Consulting
- Contaminant Analysis
- Contract Research (CRO)
- Dosage Form Development
- Drug Development
- Contract Development
- Excipients
- Testing
- Feasibility Studies
- Flavours
- Forced Degradation Studies
- Process Development
- Formulation Development
- Controlled Release
- Gene Therapy & Testing Protocols
- Imaging
- In Vitro Testing
- Lead Optimization
- Lot Release Testing
- Mass Spectrometry
- Materials Analysis
- Measuring & Testing Technology
- Clinical Studies
- Micro FT-IR Analysis
- Microscopic Analysis
- Nutritional Support Analysis
- Packaging
- Anti-Counterfeiting
- Design & Testing
- Parenterals
- Particle Characterization
- Particle Size Analysis
- Particle Size Classification
- Pharmacokinetics
- Pharmacology
- Photostability
- Physical Testing
- Preclinical Testing
- Preclinical Testing Formulations
- Preformulation
- Process Characterization
- Quality QA/QC
- R&D Services
- Raw Materials Analysis
- Screening
- Classifying
- Stability Studies
- Stability
- ICH
- Target Profiling
- Technology Transfer
- Thermogravimetric Analysis
- Trace Metal Analysis
- ICP
- UV-VIS Spectrophotometer Analysis
- Validation
- Vitamin Analysis
- Wet Chemical Analysis
- X-Ray Crystallography
- X-Ray Powder Diffraction

Resolian remains committed to delivering high-quality research and analytical services tailored to clients’ needs, ensuring compliance and innovation in drug development. For more information, please visit resolian.com.